Laboratory information system (LIS) are used to manage various tasks in the laboratory, including workflow management, integrate instruments, records management, logistics management, decision making, enterprise resource planning, privacy, and security controls. Laboratories generate an ample amount of data that can be managed through LIS.
Thermo Fischer Scientific Inc. and CompuGroup Medical – Notable Market Players in Laboratory Information System (LIS) Market
The laboratory information system (LIS) market majorly consists of the players such as Thermo Fisher Scientific Inc.; Illumina, Inc.; LABWORKS; LabLynx, Inc.; LabVantage Solutions, Inc.; Francisco Partners; CompuGroup Medical; Hex Labs; AAC Infotray AG, and McKesson Corporation. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized strategies such as product launches, expansions, and product upgradations for the growth of their organizations. The companies have adopted several inorganic and organic strategies to accelerate their growth and improve their market position.
Below is the list of the growth strategies done by the players operating in the laboratory information system (LIS) market :
Normal
0
false
false
false
EN-US
JA
X-NONE
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:”Table Normal”;
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:””;
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-para-margin-top:0cm;
mso-para-margin-right:0cm;
mso-para-margin-bottom:8.0pt;
mso-para-margin-left:0cm;
line-height:107%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:”Calibri”,sans-serif;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:”Times New Roman”;
mso-bidi-theme-font:minor-bidi;
mso-ansi-language:EN-US;
mso-fareast-language:EN-US;}
table.PlainTable11
{mso-style-name:”Plain Table 11″;
mso-tstyle-rowband-size:1;
mso-tstyle-colband-size:1;
mso-style-priority:41;
mso-style-unhide:no;
border:solid #BFBFBF 1.0pt;
mso-border-themecolor:background1;
mso-border-themeshade:191;
mso-border-alt:solid #BFBFBF .5pt;
mso-border-themecolor:background1;
mso-border-themeshade:191;
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-border-insideh:.5pt solid #BFBFBF;
mso-border-insideh-themecolor:background1;
mso-border-insideh-themeshade:191;
mso-border-insidev:.5pt solid #BFBFBF;
mso-border-insidev-themecolor:background1;
mso-border-insidev-themeshade:191;
mso-para-margin:0cm;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:”Calibri”,sans-serif;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:”Times New Roman”;
mso-bidi-theme-font:minor-bidi;
mso-ansi-language:EN-US;
mso-fareast-language:EN-US;}
table.PlainTable11FirstRow
{mso-style-name:”Plain Table 11″;
mso-table-condition:first-row;
mso-style-priority:41;
mso-style-unhide:no;
mso-ansi-font-weight:bold;
mso-bidi-font-weight:bold;}
table.PlainTable11LastRow
{mso-style-name:”Plain Table 11″;
mso-table-condition:last-row;
mso-style-priority:41;
mso-style-unhide:no;
mso-tstyle-border-top:1.5pt double #BFBFBF;
mso-tstyle-border-top-themecolor:background1;
mso-tstyle-border-top-themeshade:191;
mso-ansi-font-weight:bold;
mso-bidi-font-weight:bold;}
table.PlainTable11FirstCol
{mso-style-name:”Plain Table 11″;
mso-table-condition:first-column;
mso-style-priority:41;
mso-style-unhide:no;
mso-ansi-font-weight:bold;
mso-bidi-font-weight:bold;}
table.PlainTable11LastCol
{mso-style-name:”Plain Table 11″;
mso-table-condition:last-column;
mso-style-priority:41;
mso-style-unhide:no;
mso-ansi-font-weight:bold;
mso-bidi-font-weight:bold;}
table.PlainTable11OddColumn
{mso-style-name:”Plain Table 11″;
mso-table-condition:odd-column;
mso-style-priority:41;
mso-style-unhide:no;
mso-tstyle-shading:#F2F2F2;
mso-tstyle-shading-themecolor:background1;
mso-tstyle-shading-themeshade:242;}
|
Year |
News |
| Jan-2022 | Thermo Fisher Scientific announced the release of Thermo Scientific Watson LIS software version 7.7. New and enhanced features in Watson LIS software version 7.7 include Internal Standard Review, Import Study Protocol usability improvements, %CV of concentration flagging additions, analytical run processing enhancements, CDISC SDTM support, sample home position, and additional Immune Response result filters. The release also delivers product health updates including resolution of ~ 100 defects, testing against a newer Oracle character set and alternate Delivery Mode option (Microsoft RemoteApp), and performance improvements in the archive/dearchive process. |
| Nov-2021 | Thermo Fisher Scientific announced the release of Thermo Scientific SampleManager LIS software version 21.0. New features in SampleManager LIS software version 21.0 include PostgreSQL database support, enhanced user interface for dynamic data approval, and statistical data analysis through integration with R Script with enhancements to the existing Electronic Lab Notebook, contract testing portal, and translation features. The release also delivers a significant product health update through the resolution of 190 SCR defects. |
| Jun-2021 | STARLIS SDMS V12.2 can work with an existing LIS or without a LIMS, interfacing effectively with any LIS (Laboratory Information Management System), CDS (Chromatography Data System), ELN (Electronic Laboratory Notebook), SAP (Systems Applications Products), and other lab systems through web services without replacing them. |
| May-2022 | Illumina, Inc. a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, announced a five-year partnership to apply a genetic-led approach to the discovery and development of novel therapies for diseases with unmet medical needs. The partnership aims to leverage genomic tools and genetic knowledge to select programs with a higher probability of success in order to lower research and development costs and accelerate the approval of cutting-edge therapies. |
| Apr-2021 | LabVantage Solutions, Inc., announced that it has partnered with Holo4Med to further expand its healthcare presence in Europe. Through this strategic partnership, Holo4Med as a medical technology company will take part in the continuity and productivity of LabVantage Medical Suite services in the region. |
